Content about Factor X

July 11, 2012
BioRx receives distribution rights to bleeding disorder drug

Days after its acquisition of Coagulife, specialty pharmacy provider BioRx has received limited distribution rights to a treatment for a bleeding disorder described as one of the rarest in the world.

February 18, 2011
FDA OKs Corifact

The Food and Drug Administration has approved a treatment for a rare bleeding disorder.

© 2013 Drug Store News. All Rights Reserved.